A 52‐week update of a multicentre Italian real‐world experience on effectiveness and safety of dupilumab in adolescents with moderate‐to‐severe atopic dermatitis
scientific article published on 18 October 2022
Author/s
author: Luca Stingeni, Maddalena Napolitano, Laura Bonzano, Anna Belloni Fortina, Anna Balato, Ketty Peris, Fabrizio Guarneri, Marco Romanelli, Paola Savoia, Maria Esposito, Enzo Errichetti, Claudio Feliciani, Nicola Milanesi, Andrea Chiricozzi, Katharina Hansel
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.